Evidence map›Paper›PMID 36911539›Full record

ReviewActa Cardiologica Sinica2023

Cancer-Associated Thrombosis: A Taiwanese Perspective on Therapeutic Options with Focus on Non-Vitamin K Antagonist Oral Anticoagulants.

Yu-Yun Shao, Ching-Liang Ho, Cheng-Shyong Chang, Chia-Lun Chang, Jen-Kuang Lee, Hung-Ju Lin, Hui-Hua Hsiao, Ta-Chung Chao, Ching-Yeh Lin, Chuang-Chi Liaw

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acta Cardiologica Sinica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Radiation Treatment Mechanisms of Cardiotoxicity: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yu-Yun ShaoDepartment of Oncology, National Taiwan University Hospital.
Ching-Liang HoDivision of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei.
Cheng-Shyong ChangDivision of Hematology-Oncology, Department of Internal Medicine, Chang Bing Show Chwan Memorial Hospital, Changhua.
Chia-Lun ChangDepartment of Hematology, Taipei Municipal Wanfang Hospital.
Jen-Kuang LeeDivision of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei.
Hung-Ju LinDivision of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei.
Hui-Hua HsiaoDivision of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University and Kaohsiung Medical University Hospital, Kaohsiung.
Ta-Chung ChaoDepartment of Oncology, Taipei Veterans General Hospital, Taipei.
Ching-Yeh LinDepartment of Hematology, Changhua Christian Hospital, Changhua.
Chuang-Chi LiawDepartment of Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer-associated thrombosis (CAT) is a common complication of malignancies. Patients with CAT are at risk of venous thromboembolism recurrence, but also at risk of bleeding while anticoagulated. Taiwanese patients are perceived to have a lower incidence of CAT, likely leading to false reassurance for Taiwanese patients with cancer. Because of this, oncologists and cardiologists from multiple medical institutions in Taiwan have set forth to provide clinical consensus guidelines on the management of CAT, based on local clinical practices and guided by predominant international clinical practice guidelines. This paper aims to describe the current disease burden of cancer-associated venous thromboembolism in Taiwanese cancer patients, and discusses the unmet needs and gaps in the management of this medical complication. It also outlines diagnostic and management strategies relevant to the different treatment options available, such as non-vitamin K antagonist oral anticoagulants.

Indexed as

Cancer-associated thrombosisDeep venous thromboembolismEvidence-based guidelinesNon-vitamin K antagonist oral anticoagulantsPulmonary embolism

Identifiers

PMID36911539
PMCPMC9999188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.